FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3014454713> ?p ?o ?g. }

• W3014454713 abstract "Objective The aim of this randomized comparative study was to assess renal and metabolic effects of vildagliptin in insulin-treated type 2 diabetes (T2DM) patients without overt chronic kidney disease. Subjects and methods We randomized 47 insulin-treated non-proteinuric patients with satisfactory controlled T2DM and estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73m 2 either to continue insulin therapy (control) or to receive combined insulin-vildagliptin treatment (VIG group). We assessed eGFR using serum creatinine (eGFRcreat), cystatin C (eGFRcys), and both (eGFRcreat-cys), and urinary creatinine-adjusted excretion of albumin (UACR), type IV collagen (uCol IV/Cr), and neutrophil gelatinase-associated lipocalin (uNGAL/Cr) at baseline and after 6 months of treatment. Results Study groups were comparable in terms of age and sex (60.1 ± 6.1 years and 42.9% men in control group vs. 60.8 ± 5.2 years and 39.1% in VIG group). After 6 months of treatment, there were no significant changes in main assessed parameters in control group. VIG group demonstrated significant decrease in HbA1c, diastolic blood pressure, frequency of hypoglycemia, and high-sensitivity C-reactive protein level as compared to the changes in control group. While eGFRcreat, UACR, and uNGAL/Cr showed no significant changes after vildagliptin addition, eGFRcys, eGFRcreat-cys, and uCol IV/Cr changed significantly in comparison with control group (+7.0% [3.7;13.3]; +5.1% [1.4;8.5]; -32,8% [-55.8;-24.4], respectively, p < 0.01 each). Correlation and regression analysis revealed glucose-independent pattern of these changes. Conclusion Addition of vildagliptin to ongoing insulin therapy in patients with T2DM was associated with a reduction in uCol IV/Cr and an increase in eGFRcys and eGFRcreat-cys, independent of T2DM control parameters." @default.
• W3014454713 created "2020-04-10" @default.
• W3014454713 creator A5000163333 @default.
• W3014454713 creator A5004806828 @default.
• W3014454713 creator A5009480594 @default.
• W3014454713 creator A5016802820 @default.
• W3014454713 creator A5018911416 @default.
• W3014454713 creator A5030003823 @default.
• W3014454713 creator A5034052443 @default.
• W3014454713 creator A5041481125 @default.
• W3014454713 creator A5058303499 @default.
• W3014454713 creator A5067346800 @default.
• W3014454713 creator A5086065407 @default.
• W3014454713 date "2020-03-30" @default.
• W3014454713 modified "2023-10-17" @default.
• W3014454713 title "Short-term renal and metabolic effects of low dose vildagliptin treatment added-on insulin therapy in non-proteinuric patients with type 2 diabetes: open-label randomized prospective study" @default.
• W3014454713 cites W1592519647 @default.
• W3014454713 cites W1818704632 @default.
• W3014454713 cites W1949907771 @default.
• W3014454713 cites W1969068062 @default.
• W3014454713 cites W1970024336 @default.
• W3014454713 cites W1971349613 @default.
• W3014454713 cites W1975165831 @default.
• W3014454713 cites W1980127270 @default.
• W3014454713 cites W1984412592 @default.
• W3014454713 cites W2010520337 @default.
• W3014454713 cites W2015143075 @default.
• W3014454713 cites W2027445170 @default.
• W3014454713 cites W2041165407 @default.
• W3014454713 cites W2050003893 @default.
• W3014454713 cites W2104763836 @default.
• W3014454713 cites W2109077746 @default.
• W3014454713 cites W2109416725 @default.
• W3014454713 cites W2118625269 @default.
• W3014454713 cites W2118812428 @default.
• W3014454713 cites W2121242002 @default.
• W3014454713 cites W2122273643 @default.
• W3014454713 cites W2131821161 @default.
• W3014454713 cites W2148891099 @default.
• W3014454713 cites W2155965977 @default.
• W3014454713 cites W2160088494 @default.
• W3014454713 cites W2164875000 @default.
• W3014454713 cites W2166051277 @default.
• W3014454713 cites W2287125846 @default.
• W3014454713 cites W2314611774 @default.
• W3014454713 cites W2344940232 @default.
• W3014454713 cites W2400732605 @default.
• W3014454713 cites W2413263575 @default.
• W3014454713 cites W2425198816 @default.
• W3014454713 cites W2426723940 @default.
• W3014454713 cites W2432147179 @default.
• W3014454713 cites W2516174926 @default.
• W3014454713 cites W2607031541 @default.
• W3014454713 cites W2617258928 @default.
• W3014454713 doi "https://doi.org/10.20945/2359-3997000000220" @default.
• W3014454713 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32267348" @default.
• W3014454713 hasPublicationYear "2020" @default.
• W3014454713 type Work @default.
• W3014454713 sameAs 3014454713 @default.
• W3014454713 citedByCount "1" @default.
• W3014454713 countsByYear W30144547132020 @default.
• W3014454713 crossrefType "journal-article" @default.
• W3014454713 hasAuthorship W3014454713A5000163333 @default.
• W3014454713 hasAuthorship W3014454713A5004806828 @default.
• W3014454713 hasAuthorship W3014454713A5009480594 @default.
• W3014454713 hasAuthorship W3014454713A5016802820 @default.
• W3014454713 hasAuthorship W3014454713A5018911416 @default.
• W3014454713 hasAuthorship W3014454713A5030003823 @default.
• W3014454713 hasAuthorship W3014454713A5034052443 @default.
• W3014454713 hasAuthorship W3014454713A5041481125 @default.
• W3014454713 hasAuthorship W3014454713A5058303499 @default.
• W3014454713 hasAuthorship W3014454713A5067346800 @default.
• W3014454713 hasAuthorship W3014454713A5086065407 @default.
• W3014454713 hasBestOaLocation W30144547131 @default.
• W3014454713 hasConcept C126322002 @default.
• W3014454713 hasConcept C126894567 @default.
• W3014454713 hasConcept C134018914 @default.
• W3014454713 hasConcept C159641895 @default.
• W3014454713 hasConcept C168563851 @default.
• W3014454713 hasConcept C2776453732 @default.
• W3014454713 hasConcept C2777180221 @default.
• W3014454713 hasConcept C2779306644 @default.
• W3014454713 hasConcept C2779548226 @default.
• W3014454713 hasConcept C2780306776 @default.
• W3014454713 hasConcept C2780668416 @default.
• W3014454713 hasConcept C555293320 @default.
• W3014454713 hasConcept C71924100 @default.
• W3014454713 hasConcept C90924648 @default.
• W3014454713 hasConceptScore W3014454713C126322002 @default.
• W3014454713 hasConceptScore W3014454713C126894567 @default.
• W3014454713 hasConceptScore W3014454713C134018914 @default.
• W3014454713 hasConceptScore W3014454713C159641895 @default.
• W3014454713 hasConceptScore W3014454713C168563851 @default.
• W3014454713 hasConceptScore W3014454713C2776453732 @default.
• W3014454713 hasConceptScore W3014454713C2777180221 @default.
• W3014454713 hasConceptScore W3014454713C2779306644 @default.
• W3014454713 hasConceptScore W3014454713C2779548226 @default.
• W3014454713 hasConceptScore W3014454713C2780306776 @default.
• W3014454713 hasConceptScore W3014454713C2780668416 @default.
• W3014454713 hasConceptScore W3014454713C555293320 @default.

• next